These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10640290)

  • 1. Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat.
    Friedrich AE; Gebhart GF
    J Pharmacol Exp Ther; 2000 Feb; 292(2):538-44. PubMed ID: 10640290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of visceral hyperalgesia by morphine and cholecystokinin from the rat rostroventral medial medulla.
    Friedrich AE; Gebhart GF
    Pain; 2003 Jul; 104(1-2):93-101. PubMed ID: 12855318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.
    Sullivan AF; Hewett K; Dickenson AH
    Brain Res; 1994 Oct; 662(1-2):141-7. PubMed ID: 7859067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress reduces morphine's antinociceptive potency: dependence upon spinal cholecystokinin processes.
    Hawranko AA; Smith DJ
    Brain Res; 1999 Apr; 824(2):251-7. PubMed ID: 10196456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potentiation of morphine- and ohmefentanyl-induced analgesia by cholecystokinin receptor antagonists in rat].
    Zhou Y; Sun YH; Han JS
    Sheng Li Xue Bao; 1993 Jun; 45(3):255-61. PubMed ID: 8235725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment.
    Lavigne GJ; Millington WR; Mueller GP
    Neuropeptides; 1992 Feb; 21(2):119-29. PubMed ID: 1557183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
    Kellstein DE; Mayer DJ
    Brain Res; 1990 May; 516(2):263-70. PubMed ID: 2364292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord.
    Zhou Y; Sun YH; Zhang ZW; Han JS
    Eur J Pharmacol; 1993 Apr; 234(2-3):147-54. PubMed ID: 8387008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK(B) receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics.
    Idänpään-Heikkilä JJ; Perrot S; Guilbaud G; Kayser V
    Eur J Pharmacol; 1997 May; 325(2-3):155-64. PubMed ID: 9163562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between antinociception induced by cholecystokinin antagonists and GABA agonists in the tail-flick test.
    Zarrindast MR; Rezayat M; Ghanipoor N; Parvini S
    Pharmacol Toxicol; 1998 Oct; 83(4):143-8. PubMed ID: 9820874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of spinal cholecystokininB receptors in mediating neurotensin hyperalgesia from the medullary nucleus raphe magnus in the rat.
    Urban MO; Smith DJ; Gebhart GF
    J Pharmacol Exp Ther; 1996 Jul; 278(1):90-6. PubMed ID: 8764339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation.
    Stanfa LC; Dickenson AH
    Br J Pharmacol; 1993 Apr; 108(4):967-73. PubMed ID: 8485635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
    Honore P; Buritova J; Fournié-Zaluski MC; Roques BP; Besson JM
    J Pharmacol Exp Ther; 1997 Apr; 281(1):208-17. PubMed ID: 9103499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of spinal cholecystokinin and neurokinin-1 receptors is associated with the attenuation of intrathecal morphine analgesia following electroacupuncture stimulation in rats.
    Fukazawa Y; Maeda T; Kiguchi N; Tohya K; Kimura M; Kishioka S
    J Pharmacol Sci; 2007 Jun; 104(2):159-66. PubMed ID: 17558184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin receptor mechanism(s) and morphine tolerance in mice.
    Zarrindast MR; Nikfar S; Rezayat M
    Pharmacol Toxicol; 1999 Jan; 84(1):46-50. PubMed ID: 9974190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
    Valverde O; Maldonado R; Fournie-Zaluski MC; Roques BP
    J Pharmacol Exp Ther; 1994 Jul; 270(1):77-88. PubMed ID: 8035345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-740,093, a new antagonist of the CCK-B receptor, potentiates the antinociceptive effect of morphine: electrophysiological and behavioural studies.
    Xu XJ; Hoffmann O; Wiesenfeld-Hallin Z
    Neuropeptides; 1996 Apr; 30(2):203-6. PubMed ID: 8771563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrindole, an opioid delta antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat.
    Ossipov MH; Kovelowski CJ; Vanderah T; Porreca F
    Neurosci Lett; 1994 Nov; 181(1-2):9-12. PubMed ID: 7898778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin potentiates morphine anticonvulsant action through both CCK-A and CCK-B receptors.
    Legido A; Adler MW; Karkanias C; Geller EB; Bradley E; Greenstein JI; Grover WD
    Neuropeptides; 1995 Feb; 28(2):107-13. PubMed ID: 7746354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caerulein may potentiate morphine-induced antinociception by cholecystokinin-A and/or cholecystokinin-B receptor mechanisms.
    Rezayat M; Oreizi S; Zarrindast MR
    Gen Pharmacol; 1997 Feb; 28(2):337-40. PubMed ID: 9013214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.